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We have completed a genome scan of a 12-generation, 3,400-member pedigree with schizophrenia. Samples from
210 individuals were collected from the pedigree. We performed an “affecteds-only” genome-scan analysis using
43 members of the pedigree. The affected individuals included 29 patients with schizophrenia, 10 with schizoaffective
disorders, and 4 with psychosis not otherwise specified. Two sets of white-European allele frequencies were
used—one from a Swedish control population (46 unrelated individuals) and one from the pedigree (210 individuals).
All analyses pointed to the same region: D6S264, located at 6q25.2, showed a maximum LOD score of 3.45 when
allele frequencies in the Swedish control population were used, compared with a maximum LOD score of 2.59
when the pedigree’s allele frequencies were used. We analyzed additional markers in the 6q25 region and found a
maximum LOD score of 6.6 with marker D6S253, as well as a 6-cM haplotype (markers D6S253–D6S264) that
segregated, after 12 generations, with the majority of the affected individuals. Multipoint analysis was performed
with the markers in the 6q25 region, and a maximum LOD score of 7.7 was obtained. To evaluate the significance
of the genome scan, we simulated the complete analysis under the assumption of no linkage. The results showed
that a LOD score 12.2 should be considered as suggestive of linkage, whereas a LOD score 13.7 should be considered
as significant. These results suggest that a common ancestral region was inherited by the affected individuals in
this large pedigree.
Introduction
Mapping disease loci that predispose to mental disorders
is difficult because of several obstacles, including non-
Mendelian inheritance, phenotype definition, and gene
and allele heterogeneity. One way to overcome these
barriers is to study a single extended pedigree. The pre-
sent study considers one of the world’s largest reported
pedigrees with individuals suffering from schizophrenia
(MIM 181500). The pedigree has been traced back to
the 17th century and comprises ∼3,400 individuals span-
ning 12 generations. Here we report a complete genome
scan for 43 affected individuals and 167 close relatives
collected from the pedigree (in fig. 1, genotyped indi-
viduals are indicated by gray boxes). Genotyping was
done with 371 markers. Four different phenotypic cri-
teria were used for the linkage analysis: (i) schizophrenia
only (Scz); (ii) schizophrenia and schizoaffective de-
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pressed type (SAD); (iii) schizophrenia, schizoaffective
depressed type, and psychosis not otherwise specified
(NOS) (Brd1); and (iv) all the previously mentioned di-
agnoses and schizoaffective bipolar type (Brd2). Only
the affected members of the pedigree were included in
the LOD-score calculations. A caveat for our analysis is
that, in a large pedigree such as that presented here, it
is not possible to type all individuals from all generations
to accurately determine the phase for all alleles. There-
fore, it is important to estimate accurate allele frequen-
cies for the linkage analysis (Boehnke 1991; Ott 1992;
Freimer et al. 1993; Nechiporuk et al. 1993). To tackle
this problem, we generated two sets of Swedish allele
frequencies. The first set of allele frequencies was ob-
tained from 46 unrelated individuals from the same ge-
ographic area (i.e., northern Sweden) inhabited by the
pedigree; this group was used because a control sample
from northern Sweden would tend to allow reliable es-
timation of the frequencies of common alleles present in
the pedigree. The second set of allele frequencies used
was derived from the pedigree, including all affected and
unaffected individuals (210 individuals); this group is
biased toward a false-negative result both because it in-
cludes a large number (i.e., 43) of sick individuals and
because the penetrance of the putative schizophrenia
Figure 1 Summary drawing of a large pedigree with schizophrenia, from northern Sweden. The total pedigree consists of 3,400 individuals,
520 of whom are shown. The branches drawn were selected because they contain affected individuals who have given consent to be included
in the genome scan and their closest relatives. The upper part of the pedigree, drawn in black, shows the first generations in the 17th century
and the connections between the four branches drawn below. We have obtained blood samples from and have genotyped all the 210 individuals
indicated by gray boxes. For simplicity, deceased individuals are not indicated.
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gene is not known. Our analysis revealed, at 6q25, a
candidate schizophrenia-susceptibility locus, which was
investigated by a fine-mapping strategy.
Subjects, Material, and Methods
Pedigree Construction and Clinical Assessment
A pedigree consisting of 3,400 individuals spanning
12 generations was constructed on the basis of church
records, old psychiatric records, national registers, and
information from a Ph.D. thesis (Sjo¨gren 1935). All 43
patients included in the genome scan received, before the
start of the project, diagnoses within the “core spectrum
of schizophrenia”—that is, Scz, schizoaffective psycho-
sis, or psychosis not otherwise specified, according to
DSM-III-R and/or the ICD-9 diagnostic systems. The
original diagnosis and the number of previous hospi-
talizations were obtained from the official Swedish in-
patient psychiatric register. The patients were contacted
again after 1994 and were asked to participate in the
project. From 1994 to 2000, 34 of the 43 patients were
interviewed again. Of these 34 patients, 26 were inter-
viewed by means of the Swedish version of the Diag-
nostic Interviews for Genetic Studies (DIGS) (Nurnber-
ger et al. 1994); for the other 8 patients, a reliable and
complete DIGS analysis was not possible, because of
their psychiatric condition at the time of the interview.
The remaining 9 of the 43 patients could not be inter-
viewed again. Of these 9 patients, 6 died after the col-
lection of blood samples, and 3 could not be assessed,
because of either dementia (1 case), deafness (1 case),
or stroke (1 case). For the 17 cases for which a complete
DIGS analysis was not done after 1994, information
from psychiatric unstructured interviews, psychiatric re-
cords, clinicians, and interviews with first-degree rela-
tives, by means of the Family Interview for Genetic Stud-
ies (FIGS) (Nurnberger et al. 1994), was considered
sufficient for confirmation of the official clinical diag-
nosis. The relatives of affected individuals were inter-
viewed face-to-face and/or over the telephone. The phe-
notypes of the relatives were considered as “unknown”
for the statistical analysis. All clinical data obtained after
1994, including those from DIGS, unstructured inter-
views, psychiatric records, and FIGS, were added to the
Swedish version of the OPCRIT 3.3 (Operational Cri-
teria Checklist) (McGuffin et al. 1991). After 1994, all
43 affected individuals received DSM-IV and OPCRIT
diagnosis, with the following distribution: Scz (29 cases);
schizoaffective disorder, depressed type (6 cases), schi-
zoaffective disorder, bipolar type (4 cases); and NOS (4
cases). The OPCRIT-based diagnosis and the DSM-
IV–based diagnosis were in full agreement. All diagnoses
were established by two psychiatrists independently. The
patients included 21 females with a mean age, at the
time of the blood extraction, of 55 years (54.9  15.5
years) and a mean age at onset of about 27 years (26.6
 8.9years ). The 22 males had a mean age of ∼50 years
(50.4  15.2 years) and a mean age at onset of ∼24
years (24.2  7.3 years).
Blood was collected from the 43 affected individuals
and their closest relatives, resulting in a total of 210
blood samples that were included in the genome scan
(see fig. 1, where genotyped individuals are indicated by
gray shading). The collection of all the blood samples
was done by the Research Unit at the Department of
Clinical Sciences, Division Psychiatry, at Umea˚ Univer-
sity in Sweden.
Genotyping
We used 371 polymorphic microsatellite markers. In-
formation about many of the primers used for genotyp-
ing and about sequences, heterozygosity, and allele sizes
were obtained from The Genetic Location Database
(Collins et al. 1996) and The Genome Database. The
information for some additional, improved markers, as
well as linkage-map information on the markers used
was extracted from the databases at Axys Pharmaceu-
ticals. The average marker spacing in the genome scan
was ∼10 cM. There were eight gaps 130 cM; these gaps
do not correspond to regions previously suggested to
contain schizophrenia loci. The alleles for the markers
were assigned by means of an approach for high-
throughput genotyping (Hall et al. 1996). Multiple ali-
quots of the DNA extracted from the 210 individuals,
with a concentration of 4 ng/ml, were dried in multiple
96-well replica plates. PCR mixing and the dispensing
of mixes into the 96-well plates with the patients’ DNA
were performed by a Packard Robotic System Multi-
probe 204 (Packard Instruments). Each PCR reaction
was 20 ml, containing 2 ml of 10 mM dNTP, 2 ml of 10
# PCR buffer, and 1 ml 50 of mM MgCl2. The DNA
was subject to PCR in a MJ PTC-100  (MJ Research).
Markers were amplified separately, and then 8-16 mark-
ers were pooled according to panel-set category. Pooling
was performed by a CRS/MultiPette Work Cell (CRS
Robotics). The pooled samples were then loaded onto
an ABI 373 or an ABI 377 (Applied Biosystems), de-
pending on the resolution necessary for the markers.
Thirty-three panel sets resulted in a total of 371markers.
The results were analyzed by GENOTYPER version 2.1
(Applied Biosystems). An additional genome scan was
performed, with the same 371 markers, on 46 healthy
individuals originating from the same geographic area
inhabited by the pedigree. This was done to obtain allele
frequencies in the Swedish control population, to be used
in the linkage analyses.
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Figure 2 Genomewide simulation analysis. The upper graph
shows the number of expected MLS values at or above a given MLS
threshold, under the assumption of no linkage. This is equivalent to
the average number of expected false-positive hits at or above each
threshold, plotted on a logarithmic scale. Suggestive MLS values (1
false-positive per genome scan) and significant MLS values (1 false-
positive per 20 genome scans) are indicated by, respectively, the upper
and lower dotted lines. The lower graph shows the proportion of
genome scans exceeding each MLS value, plotted on a logarithmic
scale. The dotted line represents the level.Pp .05
Statistical Analysis
Four different groups of phenotypic criteria were used
in the linkage studies: (i) Scz, (ii) SAD, (iii) Brd1, and
(iv) Brd2. Healthy members of the pedigree, as well as
individuals with other psychiatric diagnoses, were de-
noted “phenotype unknown.”
We performed a two-point linkage analysis, using the
MLINK program from the LINKAGE package (Cot-
tingham et al. 1993). We did not use allele frequencies
from The Genome Database, for two reasons: first, The
Genome Database frequencies are, in most cases, derived
from a relatively small number of chromosomes, which
might result in inaccurate frequencies that can give spu-
rious results; second, the analyses of the Swedish control
population and of the pedigree were done with the same
set of tools, ensuring a correct identification of alleles in
both groups. For the calculations, we used the same
model that had been presented in our previous repli-
cation work on chromosome 6p23 (Lindholm et al.
1999); in brief, a model assuming a dominant trait was
used. The sporadic risk was set to 0.4%, the mutation
rate was 106, and a maximum penetrance of .4 was
used (Levinson et al. 1996). To avoid the problem of
low penetrance of schizophrenia, only the affectedmem-
bers were included in the calculations. Linkage analyses
were also performed with an additional set of allele fre-
quencies. The second set of allele frequencies was ob-
tained from the distribution of alleles in the pedigree
analyzed in the genome scan. For saturation mapping,
a third set of allele frequencies, from 46 healthy indi-
viduals from northern Sweden, was used, depending on
the availability of samples at the time for the analysis.
To evaluate the significance of the results, we per-
formed simulations of the complete genome-scan data.
This analysis was performed at the PDC (Parallel Data
Center) in Stockholm. We simulated the complete ge-
nome-scan data, for the two sets of frequencies and four
diagnostic groups (eight models), 100 times. For each
simulated replicate of the genome scan, we analyzed all
markers by means of the eight models. We therefore
performed 37,000 simulations and 296,000 LOD-score
calculations under the assumption of no linkage. We
have reduced the number of alleles for each marker to
five. For each marker, we noted both the maximumLOD
score (MLS) under each of the eight models and theMLS
of all eight models. For all genome-scan replicates, we
then calculated, for the eight-model MLS, the average
(and SD) number of LOD scores that exceeded each
threshold (fig. 2A) and the proportion of genome-scan
replicates that had at least one LOD score that exceeded
each threshold (fig. 2B). A suggestive LOD-score thresh-
old was considered as being the eight-model MLS value
expected once in each genome scan; a significant LOD-
score threshold was the average eight-model MLS value
that would be expected to occur, by chance, once in 20
genome scans. A similar analysis has been published else-
where (Sawcer et al. 1997).
We performed a three-point linkage analysis, using the
FASTLINK program from the LINKAGE package (Cot-
tingham et al. 1993). Seven markers were included in
the calculations. The genetic distances were taken from
The Genetic Location Database (Collins et al. 1996).
The EHPLUS package (Zhao et al. 2000) was used to
estimate the difference between the frequency of the
6q25 haplotype in 43 affected individuals and that in
46 unrelated controls.
Results
LOD-score data on the four different diagnostic groups
described above (see the Subjects, Material, and Meth-
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Table 1
Markers with MLS Values 11.5, for Allele Frequencies in the
Swedish Control Population and for Allele Frequencies in the
Pedigree, for Four Diagnostic Categories
CHROMOSOME
AND MARKER
RESULTS FOR ALLELE
FREQUENCIES FROM
CONTROL POPULATION
RESULTS FOR
ALLELE FREQUENCIES
FROM PEDIGREE
MLS (va) Diagnosis MLS (va) Diagnosis
2:
D2S337 2.60 (.15) Scz .00 (.35) Scz
D2S151 1.72 (.15) Scz .95 (.15) Scz
D2S125 2.14 (.20) Brd1 .34 (.30) Brd2
3:
D3S1297 1.72 (.15) Brd1 .01 (.30) Scz
D3S1304 2.72 (.10) Brd1 .57 (.20) Brd2
D3S1263 3.30 (.15) Brd2 .30 (.25) SAD
D3S1566 1.76 (.10) Brd2 .53 (.15) Brd1
D3S1580 1.55 (.15) Scz .18 (.30) Scz
5:
D5S419 2.02 (.20) Brd1 .47 (.20) Brd2
D5S644 1.82 (.15) Scz .49 (.25) SAD
D5S433 1.59 (.20) Brd2 .08 (.30) Scz
6:
D6S344 3.60 (.05) Scz .03 (.40) Scz
D6S264 3.45 (.00) Brd1 2.59 (.00) Brd1
7:
D7S636 2.00 (.10) Scz .00 (.20) Scz
8:
D8S550 2.90 (.15) Scz .70 (.15) Scz
9:
D9S157 1.72 (.05) Scz 1.47 (.05) Scz
D9S175 2.00 (.15) SAD .00 (.20) SAD
D9S299 2.01 (.05) Brd2 1.11 (.10) Brd2
10:
D10S189 1.94 (.10) Brd2 .38 (.20) Brd2
11:
D11S1324 1.74 (.20) Brd2 .03 (.40) Scz
13:
D13S283 1.66 (.15) Scz .65 (.15) Scz
D13S152 1.58 (.20) Brd2 .04 (.35) Brd1
D13S173 1.53 (.10) SAD .53 (.15) SAD
14:
D14S258 1.60 (.15) Brd1 .00 (.20) Brd1
16:
D16S401 2.52 (.15) SAD .23 (.30) Scz
20:
D20S118 3.57 (.20) Brd2 .12 (.40) Scz
D20S178 2.70 (.15) Brd2 .10 (.25) Brd1
D20S100 1.76 (.10) Scz 1.37 (.10) Scz
D20S173 2.39 (.15) SAD .05 (.35) Scz
21:
D21S266 1.61 (.15) Scz .27 (.25) Scz
22:
D22S280 1.61 (.15) Brd2 .09 (.30) Brd2
NOTE.—The MLS values for marker D6S264, which reached sug-
gestive levels of significance in both the Swedish control population
and the pedigree, are underlined.
a Recombination fraction.
ods section), analyzed by means of allele frequencies in
the Swedish control population and in the pedigree, are
plotted in figure 3; this figure shows that linkage analyses
using allele frequencies in the Swedish control popula-
tion gave LOD scores 13 with four markers: D3S1263,
D6S344, D6S264, and D20S118. Of these, only
D6S264 gave LOD scores 12 when allele frequencies in
the pedigree were used (fig. 3B and table 1). To evaluate
the significance of the results, we performed a complete
simulation of the genome scan, using all models to cal-
culate empirical LOD scores for the pedigree, under the
assumption of no linkage. We have reduced the number
of alleles for each marker to five. We performed 37,000
simulations (370 markers simulated 100 times each) and
296,000 LOD-score calculations (each of the simulated
pedigrees was subjected to eight LOD-score calculations,
for all combinations of allele frequencies and diagnostic
groups). These simulations indicated that, for the ped-
igree structure and models used in the present study, a
LOD score 12.2 should be considered as suggestive
whereas a LOD score 13.7 should be considered as sig-
nificant (fig. 2). Table 1 shows that nine markers in-
cluded in the genome scan produced LOD scores higher
than the suggestive value of 2.2: markers D2S337,
D3S1304, D3S1263, D6S344, D6S264, D8S550,
D16S401, D20S118, and D20S173. Table 1 also in-
cludes additional markers with LOD scores 11.5, for
comparisons with other studies. All nine markers that
produced suggestive linkage results were selected for fur-
ther studies. Flanking markers on each side of these
markers were typed. The results supported only the pos-
itive linkage for D6S264. Two-point LOD scores for six
additional markers located close to D6S264 are shown
in figure 4. A two-point MLS of 6.6 was obtained with
D6S253 (marked by an arrow in fig. 4). Figure 4 also
shows haplotypes in the 6q25 region, constructed for all
affected individuals whose parents were available. For
19 affected individuals connected to the same ancestor
nine generations back, we were able to determine the
phase and the haplotype inherited from the pedigree; 11
of these 19 patients shared a 6-cM haplotype
(D6S253–D6S264), and 7 of the 19 patients shared a
part of this haplotype.
We also conducted three-point analysis of the seven
markers in the 6q25 region, using allele frequencies in
the Swedish control population, and we found an MLS
of 7.7 between markers D6S253 and D6S297 (fig. 5).
Discussion
We have conducted a genomewide screening of a very
large schizophrenia pedigree from northern Sweden, and
we have found, at 6q25, a candidate schizophrenia-sus-
ceptibility locus. To evaluate the significance of the re-
sults, the calculations should be corrected for the fact
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Figure 3 Plot of genome-scan data on 371 markers, using four diagnostic criteria and two sets of allele frequencies. The MLS for each
marker is plotted for allele frequencies in the Swedish control population (A) and in the pedigree (B). Each panel includes one plot for each of
the four diagnostic categories used (four plots per panel): Scz, SAD, Brd1, and Brd2. The plotted values for the LOD scores 13 are indicated
by an arrow and the marker name. The scale for each chromosome reflects the number of markers typed, rather than the size of the chromosome.
that we performed multiple tests. A very stringent cor-
rection would be to decrease the value of all the LOD
scores by log(8) p 0.9, since we have used four types
of diagnosis and two sets of allele frequencies. This cor-
rection, which would render all of our reported LOD
scores as not significant, is not very appropriate, since
the four phenotypes are correlated. As an alternative,
we performed a complete simulation of the genome scan,
using all eight models to calculate empirical LOD scores
for the pedigree, under the assumption of no linkage.
These simulations indicated that, with the pedigree struc-
ture and models used in the present study, a LOD score
12.2 should be considered as suggestive whereas a LOD
score 13.7 should be considered as significant. As men-
tioned above, the highest linkage value in the genome
scan was reached with marker D6S264 on chromosome
6q25 (table 1). The results for this marker reached sug-
gestive values of significance, according to our simula-
tion studies. The fact that D6S264 was the only marker
that gave consistent results with the two sets of allele
frequencies further strengthens the significance of these
results.
Additionally, D3S1263 located on 3p25, D6S344 lo-
cated on 6p24, and D20S118 located on 20p11.2
showed the highest suggestive values (MLSs of 3.30,
3.60 and 3.57, respectively). MarkerD6S344 gave an
MLS of 3.6. This marker is located on 6p24, a region
that others (Straub et al. 1995; Schizophrenia Linkage
Collaborative Group for Chromosomes 3, 6 and 8
1996; Turecki et al. 1997; Nurnberger and Foroud
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Figure 4 Haplotype analysis of the 6q25 region. In the table, a haplotype (indicated by gray shading) close to marker D6S264 is shown,
for 19 affected individuals whose phase is known. Only the haplotype that is transferred from the pedigree (and not from the in-married parent)
is shown. For the individuals in whom a marker was uninformative, the allele included in the haplotype is indicated by stippling. Both alleles
are indicated for genotypes for which phase is unknown. Haplotypes from siblings are not separated by a vertical black line. The tale also
shows, for each marker, the LOD score, the recombination fraction (v), and the diagnosis that gave the MLS. The circles to the right of the
table show allele frequencies in affected individuals and in the Swedish control population. Alleles that are represented in the haplotype are
indicated by gray shading.
1999) have suggested as containing a schizophrenia-
susceptibility locus. In fact, we elsewhere have published
a part of the 3,400-member pedigree (i.e., ∼2,000 mem-
bers), in an attempt to replicate findings for chromo-
some 6p (Lindholm et al. 1999). D6S344 is located ∼2
cM frommarker D6S277, contained in a haplotype that
was found to segregate with the disease in a small
branch of the pedigree (Lindholm et al. 1999); however,
one possibility is that D3S1263 (LOD score 3.3),
D6S344 (LOD score 3.6), and D20S118 (LOD score
3.6) are false-positive results, since the calculationswere
not consistent for both sets of allele frequencies. The
results stress the importance of an accurate evaluation
of allele frequencies used in the analysis of extended
pedigrees. Another possibility is that there is hetero-
geneity inside the pedigree, with one or more of these
markers segregating with a schizophrenia locus in just
one part of the pedigree.
LOD scores were calculated for additional markers
in the 6q25 region, and several of them reached sug-
gestive or significant values, as shown in figure 4. One
problem in this region is that the alleles present in the
haplotype segregating in the pedigree are frequent in the
Swedish control population, a finding that decreases
their informativeness for LOD-score calculations (in fig.
4, circles represent allele frequencies in the affected in-
dividuals in the pedigree and in a Swedish control pop-
ulation). However, marker D6S253 (indicated by an
arrow in fig. 4), which has a more-even allele distri-
bution, resulted in an MLS of 6.6. According to the
three-point analysis (fig. 5), it is possible that a schizo-
phrenia-susceptibility gene is located in the region be-
tween markers D6S253 and D6S297, a region that
reached an MLS of 7.7. The haplotypes shown in figure
4 supports this finding, except in the case of patient
135; it is possible that allele 2 for marker D6S297 has
mutated to allele 3 in this individual; an alternative
explanation is that this individual is a phenocopy. All
other individuals have either the complete haplotype (11
of 19 patients for whom we could determine haploty-
pes) or part of it (7 of 19 patients). We were not able
to collect, for haplotype analysis, all the parents of the
43 affected individuals. Therefore, we used the EHPLUS
package (Zhao et al. 2000) to estimate the frequency
of the D6S253 (allele 2)–D6S297 (allele 2)–D6S264
(allele 4) haplotype in the 43 affected individuals from
the pedigree versus that in 46 unrelated controls. We
found a significant increase in the frequency of this 6-
cM haplotype in the pedigree compared with the con-
trols: empirical for a model-free analysis; inPp .004
light of the frequency of the haplotype in the normal
population, this P value indicates a significant proba-
bility that this region has been inherited by the affected
individuals IBD. This result suggests that the increase
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Figure 5 Multipoint analysis of the markers in the 6q25 region,
performed by use of diagnostic category Brd1 and allele frequencies
in the Swedish control population. Three-point LOD scores were cal-
culated and plotted against the distance (in cM) from the p-terminal.
The MLS was obtained between markers D6S253 and D6S297 and
reached a value of 7.7.
in haplotype frequency in the pedigree is not due to a
common frequency of this region in the Swedish pop-
ulation. In conclusion, the EHPLUS analysis further
strengthens the possibility that this region segregates
with the disease in the large pedigree.
Previous schizophrenia genome scans have proposed
schizophrenia-susceptibility loci on 1q, 2q, 3p, 4q, 5p,
5q, 6p, 7q, 8p, 9q, 10p, 10q, 11q, 13q, 22q, and Xp
(Lasseter et al. 1995; Pulver et al. 1995; Straub et al.
1995, 1997, 1998; Gill et al. 1996; Blouin et al. 1998;
Crowe and Vieland 1998; Levinson et al. 1998; Brzus-
towicz et al. 1999, 2000; Hovatta et al. 1999; Nurn-
berger and Foroud 1999; Ekelund et al. 2000). Two of
these genome scans reported significant linkage results
(Blouin et al. 1998; Brzustowicz et al. 2000). These two
studies used dominant and recessive models for the seg-
regation analysis. In the present study, we used only a
dominant model, because we considered a dominant
segregation to be more likely in the large pedigree. The
analysis of only a dominant model decreases the risk of
type 1 errors. The studies by Blouin et al. (1998) and
Brzustowicz et al. (2000) included the analysis of mul-
tiplex families, whereas the present study includes a sin-
gle large pedigree. The analysis of a single pedigree de-
creases the probability of heterogeneity and increases
the chance of finding a single gene of major effect. Mul-
tiple susceptibility loci are most probably involved in
the etiology of schizophrenia, and the fact that these
three studies report different loci is not surprising.
Until now, a schizophrenia locus at 6q25 had not been
described; however, a 6q position closer to the centro-
mere has been proposed to contain a schizophrenia-
susceptibility locus (Cao et al. 1997; Kaufmann et al.
1998; Martinez et al. 1999). In fact, excess allele sharing
has been reported for markers in the 6q13-26 region
(Cao et al. 1997; Kaufmann et al. 1998); however, the
6q23-q26 region was excluded in a follow-up multi-
center study, and only 12 microsatellite markers span-
ning 6q13-q23 were investigated (Martinez et al. 1999).
The 6q23-q26 region was most likely excluded because
the P values for the markers in this region were lower
than those for the markers on 6q13-q23. The possibility
remains that all the studies of the 6q region describe a
single schizophrenia locus.
Interestingly, an autism-susceptibility locus also has
been mapped to the 6q25 region (Philippe et al. 1999),
and deletions of the 6q25 segment can result in devel-
opmental problems and anomalies of the brain (Suku-
mar et al. 1999). These results suggest that genes im-
portant for normal brain function and development are
located on 6q25.
In summary, we have analyzed the world’s largest
reported pedigree with individuals affected with schizo-
phrenia and have found a candidate schizophrenia-sus-
ceptibility locus at 6q25. The fact that the 6q locus
reached one of the highest LOD scores reported so far
warrants further investigations of this region, in other
families around the world.
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